Is that a ceramic pan? Doesn't really seem non-stick enough to use without oil. I'm always trying to strike a balance between avoiding PFAS from Teflon or too much fat from added oils. I tend to use just a bit of oil in a cast iron or stainless steel pan to keep it from sticking without going overboard on the extra calories.
Chef uses Original Green Pans (they are in their plant-based Amazon Store: www.amazon.com/shop/stlveggirl?ref=ac_inf_tb_vh ) and sometimes there can be some sticking. If you choose to use a little oil (spray or pour) we just like people to know that one tablespoon = 120 calories / 14g fat / 100% fat / 0 fiber. Many people (including us once upon a time) use oil quite liberally that and doesn't serve anyone well. Finding a balance that works for you is what we want our viewers to take away. Thank you so much for watching!!
Low-density lipoprotein cholesterol (LDL-C) has long been recognized as a significant risk factor for heart disease. Numerous medical studies and clinical trials have investigated the relationship between LDL-C levels and the risk of heart disease. Here is a list of some key studies and trials that have contributed to our understanding of the link between LDL-C and heart disease: 1. Framingham Heart Study (1967): The Framingham Heart Study, an iconic longitudinal study, played a pivotal role in identifying high LDL-C levels as a major risk factor for heart disease. The study followed a large cohort of participants over several decades. 2. The Multiple Risk Factor Intervention Trial (MRFIT, 1982): This trial demonstrated a clear association between elevated LDL-C levels and an increased risk of coronary heart disease (CHD) events. It highlighted the importance of cholesterol management for reducing heart disease risk. 3. The Scandinavian Simvastatin Survival Study (4S, 1994): This landmark clinical trial showed that statin therapy, which lowers LDL-C levels, significantly reduced the risk of coronary events and mortality in individuals with high cholesterol levels. 4. The Cholesterol Treatment Trialists' Collaboration (CTT, 2010): A meta-analysis of statin trials conducted by the CTT provided robust evidence that lowering LDL-C levels with statin therapy significantly reduces the risk of major cardiovascular events, including heart attacks and strokes. 5. The JUPITER Trial (2008): This trial demonstrated that statin therapy reduced cardiovascular events in individuals with normal LDL-C levels but elevated high-sensitivity C-reactive protein (hs-CRP) levels. It emphasized the importance of inflammation in heart disease and the role of statins in reducing risk. 6. The IMPROVE-IT Trial (2015): This trial investigated the benefits of further LDL-C lowering with a combination of statin therapy and ezetimibe. It provided additional evidence that lowering LDL-C levels beyond standard statin therapy can lead to further reductions in cardiovascular events. 7. The PCSK9 Inhibitor Trials (e.g., FOURIER and ODYSSEY, ongoing): Trials involving PCSK9 inhibitors, a newer class of cholesterol-lowering drugs, have shown substantial reductions in LDL-C levels and have demonstrated a corresponding decrease in cardiovascular events in high-risk patients. These studies, among others, have consistently shown a strong relationship between elevated LDL-C levels and the risk of heart disease. Lowering LDL-C through lifestyle modifications and medication has become a cornerstone of heart disease prevention and management. It's important to note that while LDL-C is a critical factor, other factors such as HDL cholesterol, triglycerides, blood pressure, and lifestyle choices also influence heart disease risk. Therefore, a comprehensive approach to cardiovascular risk reduction considers multiple risk factors. Always consult with a healthcare professional for personalized guidance on heart disease prevention and management.
This is a terrific recipe! Made it this morning, and it's great. Thanks Caryn!
Fantastic, Sharon!
Is that a ceramic pan? Doesn't really seem non-stick enough to use without oil. I'm always trying to strike a balance between avoiding PFAS from Teflon or too much fat from added oils. I tend to use just a bit of oil in a cast iron or stainless steel pan to keep it from sticking without going overboard on the extra calories.
Chef uses Original Green Pans (they are in their plant-based Amazon Store: www.amazon.com/shop/stlveggirl?ref=ac_inf_tb_vh ) and sometimes there can be some sticking. If you choose to use a little oil (spray or pour) we just like people to know that one tablespoon = 120 calories / 14g fat / 100% fat / 0 fiber. Many people (including us once upon a time) use oil quite liberally that and doesn't serve anyone well. Finding a balance that works for you is what we want our viewers to take away. Thank you so much for watching!!
Would love to know the recipe, looks like it could be good.
stlveggirl.com/recipes/not-just-eggs/ :)
Recipe?
stlveggirl.com/recipes/not-just-eggs/ :)
As soon as he called LDL "bad cholesterol" he lost all credibility
Low-density lipoprotein cholesterol (LDL-C) has long been recognized as a significant risk factor for heart disease. Numerous medical studies and clinical trials have investigated the relationship between LDL-C levels and the risk of heart disease. Here is a list of some key studies and trials that have contributed to our understanding of the link between LDL-C and heart disease:
1. Framingham Heart Study (1967): The Framingham Heart Study, an iconic longitudinal study, played a pivotal role in identifying high LDL-C levels as a major risk factor for heart disease. The study followed a large cohort of participants over several decades.
2. The Multiple Risk Factor Intervention Trial (MRFIT, 1982): This trial demonstrated a clear association between elevated LDL-C levels and an increased risk of coronary heart disease (CHD) events. It highlighted the importance of cholesterol management for reducing heart disease risk.
3. The Scandinavian Simvastatin Survival Study (4S, 1994): This landmark clinical trial showed that statin therapy, which lowers LDL-C levels, significantly reduced the risk of coronary events and mortality in individuals with high cholesterol levels.
4. The Cholesterol Treatment Trialists' Collaboration (CTT, 2010): A meta-analysis of statin trials conducted by the CTT provided robust evidence that lowering LDL-C levels with statin therapy significantly reduces the risk of major cardiovascular events, including heart attacks and strokes.
5. The JUPITER Trial (2008): This trial demonstrated that statin therapy reduced cardiovascular events in individuals with normal LDL-C levels but elevated high-sensitivity C-reactive protein (hs-CRP) levels. It emphasized the importance of inflammation in heart disease and the role of statins in reducing risk.
6. The IMPROVE-IT Trial (2015): This trial investigated the benefits of further LDL-C lowering with a combination of statin therapy and ezetimibe. It provided additional evidence that lowering LDL-C levels beyond standard statin therapy can lead to further reductions in cardiovascular events.
7. The PCSK9 Inhibitor Trials (e.g., FOURIER and ODYSSEY, ongoing): Trials involving PCSK9 inhibitors, a newer class of cholesterol-lowering drugs, have shown substantial reductions in LDL-C levels and have demonstrated a corresponding decrease in cardiovascular events in high-risk patients.
These studies, among others, have consistently shown a strong relationship between elevated LDL-C levels and the risk of heart disease. Lowering LDL-C through lifestyle modifications and medication has become a cornerstone of heart disease prevention and management. It's important to note that while LDL-C is a critical factor, other factors such as HDL cholesterol, triglycerides, blood pressure, and lifestyle choices also influence heart disease risk. Therefore, a comprehensive approach to cardiovascular risk reduction considers multiple risk factors. Always consult with a healthcare professional for personalized guidance on heart disease prevention and management.